Trials / Conditions / Adult Erythroleukemia

Adult Erythroleukemia

9 registered clinical trials studyying Adult Erythroleukemia.

Status	Trial	Sponsor	Phase
Completed	Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia NCT01870596	National Cancer Institute (NCI)	Phase 2
Completed	Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia NCT01361464	National Cancer Institute (NCI)	Phase 2
Terminated	Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute My NCT01260714	National Cancer Institute (NCI)	Phase 1
Completed	Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacit NCT01168219	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leuke NCT00658814	National Cancer Institute (NCI)	Phase 2
Completed	Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leu NCT00588991	National Cancer Institute (NCI)	Phase 1
Completed	Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Ph NCT00383474	National Cancer Institute (NCI)	Phase 1
Completed	Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blast NCT00217646	National Cancer Institute (NCI)	Phase 1
Completed	Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission NCT00093470	National Cancer Institute (NCI)	Phase 3